The substance P/ Neurokinin-1 receptor signaling drives perineural invasion in pancreatic ductal adenocarcinoma (PDAC). [PDF]
Front Cell Dev BiolSchiedlauske K +8 more
europepmc +1 more source
Naringin sensitizes nasopharyngeal carcinoma cells to paclitaxel by inducing <i>AKR1C3</i> expression. [PDF]
J Int Med ResHuang Z, Qiu Y, Liu F, Chen X, Wang X.
europepmc +1 more source
A Perspective on a Possible New Role for Bevacizumab Combined with Paclitaxel in Hormone-Resistant Metastatic Breast-Cancer Patients. [PDF]
J Clin MedAllegrini G +8 more
europepmc +1 more source
Coenzyme Q10 as an adjunctive strategy to reduce paclitaxel-induced toxicities in breast cancer: a randomized controlled trial. [PDF]
BMC Pharmacol ToxicolHassoub G +4 more
europepmc +1 more source
Laparoscopic Ovarian Metastasectomy During Intraperitoneal Administration of Paclitaxel Chemotherapy for Gastric Cancer: A Report of Six Cases. [PDF]
Case Rep SurgKawai T +10 more
europepmc +1 more source
Serial Optical Coherence Tomography Assessment of Plaque Phenotype Stabilization after Paclitaxel-Coated Balloon Treatment in De Novo Coronary Lesions. [PDF]
Yonsei Med JShin ES, Kang DO, Kim TH, Her AY, Kim S.
europepmc +1 more source
Ferroptosis Signature Correlates with Ovarian Cancer Prognosis and Chemotherapy Response. [PDF]
Int J Gen MedZhang Y, Jiang Q, Yu M, Lin C.
europepmc +1 more source
Reduced-dose dexamethasone premedication for weekly paclitaxel: a retrospective cohort study of early hypersensitivity reactions and steroid-related toxicity. [PDF]
Support Care CancerLee J, An Y, Kim IW, Ko M, Oh JM.
europepmc +1 more source
Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75 Years and Older With Unresectable Pancreatic Cancer. [PDF]
Cancer Rep (Hoboken)Ikezawa K +9 more
europepmc +1 more source